Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women.

Yeh RF, Rezk NL, Kashuba AD, Dumond JB, Tappouni HL, Tien HC, Chen YC, Vourvahis M, Horton AL, Fiscus SA, Patterson KB.

Antimicrob Agents Chemother. 2009 Jun;53(6):2367-74. doi: 10.1128/AAC.01523-08. Epub 2009 Mar 23.

PMID:
19307360
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid).

Else LJ, Taylor S, Back DJ, Khoo SH.

Antivir Ther. 2011;16(8):1139-47. doi: 10.3851/IMP1918. Review.

PMID:
22155898
[PubMed - indexed for MEDLINE]
3.

Zidovudine, lamivudine, and nelfinavir concentrations in amniotic fluid and maternal serum.

Bennetto-Hood C, Bryson YJ, Stek A, King JR, Mirochnick M, Acosta EP.

HIV Clin Trials. 2009 Jan-Feb;10(1):41-7. doi: 10.1310/hct1001-041.

PMID:
19362995
[PubMed - indexed for MEDLINE]
4.

Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women.

Mandelbrot L, Peytavin G, Firtion G, Farinotti R.

Am J Obstet Gynecol. 2001 Jan;184(2):153-8.

PMID:
11174495
[PubMed - indexed for MEDLINE]
5.

Lopinavir/ritonavir trough concentrations with the tablet formulation in HIV-1-infected women during the third trimester of pregnancy.

Calza L, Manfredi R, Trapani F, Salvadori C, Colangeli V, Borderi M, Grossi G, Motta R, Viale P.

Scand J Infect Dis. 2012 May;44(5):381-7. doi: 10.3109/00365548.2011.642306. Epub 2012 Jan 21.

PMID:
22263609
[PubMed - indexed for MEDLINE]
6.

Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis.

Dumond JB, Yeh RF, Patterson KB, Corbett AH, Jung BH, Rezk NL, Bridges AS, Stewart PW, Cohen MS, Kashuba AD.

AIDS. 2007 Sep 12;21(14):1899-907.

PMID:
17721097
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract.

Else LJ, Taylor S, Back DJ, Khoo SH.

Antivir Ther. 2011;16(8):1149-67. doi: 10.3851/IMP1919. Review.

PMID:
22155899
[PubMed - indexed for MEDLINE]
8.

Maternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virus.

Chappuy H, Tréluyer JM, Rey E, Dimet J, Fouché M, Firtion G, Pons G, Mandelbrot L.

Am J Obstet Gynecol. 2004 Aug;191(2):558-62.

PMID:
15343237
[PubMed - indexed for MEDLINE]
9.

Maternal-fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant women.

Chappuy H, Tréluyer JM, Jullien V, Dimet J, Rey E, Fouché M, Firtion G, Pons G, Mandelbrot L.

Antimicrob Agents Chemother. 2004 Nov;48(11):4332-6.

PMID:
15504861
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy.

Kwara A, Delong A, Rezk N, Hogan J, Burtwell H, Chapman S, Moreira CC, Kurpewski J, Ingersoll J, Caliendo AM, Kashuba A, Cu-Uvin S.

Clin Infect Dis. 2008 Mar 1;46(5):719-25. doi: 10.1086/527387.

PMID:
18220480
[PubMed - indexed for MEDLINE]
Free Article
11.

Pharmacokinetic modelling of efavirenz, atazanavir, lamivudine and tenofovir in the female genital tract of HIV-infected pre-menopausal women.

Dumond JB, Nicol MR, Kendrick RN, Garonzik SM, Patterson KB, Cohen MS, Forrest A, Kashuba AD.

Clin Pharmacokinet. 2012 Dec;51(12):809-22. doi: 10.1007/s40262-012-0012-y.

PMID:
23044523
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Reduced lopinavir exposure during pregnancy.

Stek AM, Mirochnick M, Capparelli E, Best BM, Hu C, Burchett SK, Elgie C, Holland DT, Smith E, Tuomala R, Cotter A, Read JS.

AIDS. 2006 Oct 3;20(15):1931-9.

PMID:
16988514
[PubMed - indexed for MEDLINE]
13.

Placental transfer and pharmacokinetics of lopinavir and other protease inhibitors in combination with nevirapine at delivery.

Gingelmaier A, Kurowski M, Kästner R, Eberle J, Mylonas I, Belohradsky BH, Friese K, Grubert TA.

AIDS. 2006 Aug 22;20(13):1737-43.

PMID:
16931938
[PubMed - indexed for MEDLINE]
14.

Trough concentrations of lopinavir, nelfinavir, and nevirapine with standard dosing in human immunodeficiency virus-infected pregnant women receiving 3-drug combination regimens.

Baroncelli S, Villani P, Floridia M, Pirillo MF, Galluzzo CM, Cusato M, Amici R, Pinnetti C, Sabbatini F, Molinari A, Tamburrini E, Regazzi M.

Ther Drug Monit. 2008 Oct;30(5):604-10. doi: 10.1097/FTD.0b013e3181867a6e.

PMID:
18728627
[PubMed - indexed for MEDLINE]
15.

Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine.

Ghosn J, Chaix ML, Peytavin G, Bresson JL, Galimand J, Girard PM, Raffi F, Cohen-Codar I, Delfraissy JF, Rouzioux C.

J Antimicrob Chemother. 2008 Jun;61(6):1344-7. doi: 10.1093/jac/dkn098. Epub 2008 Mar 13.

PMID:
18343806
[PubMed - indexed for MEDLINE]
Free Article
16.

Pregnancy-related effects on lamivudine pharmacokinetics in a population study with 228 women.

Benaboud S, Tréluyer JM, Urien S, Blanche S, Bouazza N, Chappuy H, Rey E, Pannier E, Firtion G, Launay O, Hirt D.

Antimicrob Agents Chemother. 2012 Feb;56(2):776-82. doi: 10.1128/AAC.00370-11. Epub 2011 Nov 21.

PMID:
22106227
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy.

Paredes R, Cheng I, Kuritzkes DR, Tuomala RE; Women and Infants Transmission Study (WITS) Group.

AIDS. 2010 Jan 2;24(1):45-53. doi: 10.1097/QAD.0b013e32832e5303.

PMID:
19915448
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Differential extracellular and intracellular concentrations of zidovudine and lamivudine in semen and plasma of HIV-1-infected men.

Dumond JB, Reddy YS, Troiani L, Rodriguez JF, Bridges AS, Fiscus SA, Yuen GJ, Cohen MS, Kashuba AD.

J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):156-62. doi: 10.1097/QAI.0b013e31816de21e.

PMID:
18360288
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program.

Giuliano M, Guidotti G, Andreotti M, Pirillo MF, Villani P, Liotta G, Marazzi MC, Mancini MG, Cusato M, Germano P, Loureiro S, Ceffa S, Regazzi M, Vella S, Palombi L.

J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):286-91.

PMID:
17146372
[PubMed - indexed for MEDLINE]
20.

Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA.

Feeney ER, van Vonderen MG, Wit F, Danner SA, van Agtmael MA, Villarroya F, Domingo P, Capeau J, Reiss P, Mallon PW; MEDICLAS, NECATT study groups.

AIDS. 2012 Nov 13;26(17):2165-74. doi: 10.1097/QAD.0b013e328358b279.

PMID:
22874517
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk